Similar articles

• H1N1 virus and vaccination among rheumatology patients, especially those on DMARDS.

  O'Connor MB, Rathi J, Bond U, Swan J, Phelan M. O'Connor MB, et al. Ir Med J. 2010 Apr;103(4):126-7. Ir Med J. 2010. PMID: 20491149 No abstract available.
• The new British Society for Rheumatology disease modifying anti-rheumatic drugs guidelines.

  Deighton C, Gadsby K. Deighton C, et al. Musculoskeletal Care. 2006 Sep;4(3):174-81. doi: 10.1002/msc.88. Musculoskeletal Care. 2006. PMID: 17042028 No abstract available.
• The diagnosis and management of juvenile idiopathic arthritis.

  Stanley LC, Ward-Smith P. Stanley LC, et al. J Pediatr Health Care. 2011 May-Jun;25(3):191-4. doi: 10.1016/j.pedhc.2010.12.003. Epub 2011 Feb 4. J Pediatr Health Care. 2011. PMID: 21514495 No abstract available.
• Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.

  Seidman EG, Furst DE. Seidman EG, et al. J Rheumatol. 2002 Dec;29(12):2484-7. J Rheumatol. 2002. PMID: 12465139 Review. No abstract available.
• Pharmacogenetic of antirheumatic treatments: clinical implications.

  Ferraccioli G, Tolusso B, De Santis M. Ferraccioli G, et al. Pharmacogenomics J. 2007 Feb;7(1):2-9. doi: 10.1038/sj.tpj.6500396. Epub 2006 May 9. Pharmacogenomics J. 2007. PMID: 16702980 Review.